Identification | Back Directory | [Name]
Lusutrombopag | [CAS]
1110766-97-6 | [Synonyms]
S888711 S 888711 S888711;S 888711 Lusutrombopag S-888711 (E)-3-[2,6-dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]thiazol-2-ylcarbamoyl]phenyl]-2-methylacrylic acid 2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)- | [Molecular Formula]
C29H32Cl2N2O5S | [MOL File]
1110766-97-6.mol | [Molecular Weight]
591.55 |
Hazard Information | Back Directory | [Uses]
Lusutrombopag is a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP. | [Definition]
ChEBI: Lusutrombopag is a member of cinnamic acids. |
|
|